Company news
OSR Holdings, Inc. news in 2025
OSR Holdings, Inc.'s news releases, calls and decks from 2025, newest first.
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings
December 19, 2025
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
December 2, 2025
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025
December 1, 2025
OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion
November 14, 2025
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study
November 6, 2025
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care
October 14, 2025
OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity
September 9, 2025
OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025
August 1, 2025
OSR Holdings Provides Transparency Update on Equity Financing Instruments
July 31, 2025
OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure
July 30, 2025
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology
July 24, 2025
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company
July 15, 2025
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG
July 7, 2025
OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token
May 21, 2025
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics
May 2, 2025
OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies
April 3, 2025
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer
March 25, 2025
OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination
February 13, 2025
Decks in 2025
- Investor Presentation (August 2025)
Investor deck · 26 slides · Aug 6, 2025